Address gastro-oesophageal reflux : If reflux is contributing to the bad taste, lifestyle modifications can help
CagriSema is filed T2D evidence : Tirzepatide has more extensive T2D trial data GI tolerability : CagriSema has higher overall GI event rates Conclusion# CagriSema and tirzepatide represent different strategies to the same goal: surpassing GLP-1-only weight loss
[2] Saxenda is available as a single-use injection pen in 0.6mg, 1.2mg, 1.8mg, 2.4mg, and 3mg strengths
Side effects of GLP-1 medications may be serious, including increased risk of thyroid tumors and cancer
Ritchie H, Roser M, Rosado P
Los medicamentos agonistas del receptor del pptido similar al glucagn tipo 1 (GLP-1) representan una clase teraputica avanzada utilizada principalmente para el manejo de la diabetes tipo 2 y, ms recientemente, para el control del peso corporal